Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment Tesla Launches Full SelfDriving Supervised in China After Regulatory Hurdles Facing Intense Local Competition UK Exports to US Drop 25 Following Trumps Liberation Day Tariff Measures Warren Buffetts Tiny Purchase in March Possibly Revealed in Berkshire Filing Cyberattacks Intensify as Stolen Identities Drive New Wave of Threats US GDP Growth of 2 in Early 2026 Highlights Economic Resilience Village Super Market Inc Q1 2025 Earnings Strong EPS Amid Quiet Revenue Disclosure ASML Q1 2026 Earnings EPS Beat Driven by Strong EUV Demand NVEC Q1 2026 Earnings EPS of 102 Drives Share Price Rally PXLW Q1 2026 Earnings Massive EPS Surprise of 8825 as Company Reports 1246 vs 014 Estimate Seven Hills Realty Trust SEVN Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Quarter and Slight Stock Decline CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin Revenue Details Not Provided BRC Group Holdings Senior Notes RILYN Edge Higher to 2486 as Bond Market Calms Aurora Innovation Inc AUR Edges Lower as Key Support Level Approaches nLIGHT Inc LASR Rallies 209 to 7803 Testing Key Resistance Levels Esperion Therapeutics Holds Steady Near Support Testing Key Resistance Zone T3 Defense Inc DFNS Edges Higher as Support Holds Key Levels in Focus Treasury Yield Surge Prompts Bond Investors to Seek Alternative FixedIncome Opportunities RELL Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Negatively Lakeshore Acquisition III LCCC Holds Steady at 1036 Amid SPAC Market Uncertainty First Trust Senior Floating Rate Income Fund II FCT Edges Higher as Floating Rate Exposure Provides Stability RTX Dips 13 as Defense Sector Faces Headwinds Key Support Levels in Focus FS Specialty Lending Fund FSSL Gains 189 as Shares Approach Key Resistance at 1243 Natural Gas Services Group NGS Holds Steady Above Support Eyes Resistance at 4496 Winchester Bancorp Inc WSBK Edges Lower Amid Light Trading Key Levels in Focus Nano Labs Ltd NA Holds Steady Near Support After Slight Dip Taysha Gene Therapies TSHA Holds Steady Near Support as Biotech Sentiment Improves